Alerts will be sent to your verified email
Verify Email
SMSPHARMA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
SMS Pharmaceuticals Ltd is a leading Indian pharmaceutical manufacturer with state-of-the-art facilities meeting international standards. The company received export house status in 1997-98 and serves a growing global and local customer base.
SMS Pharmaceuticals major competitors are Solara Active Pharma, Morepen Laboratories, IOL Chem & Pharma, Hester Biosciences, Bajaj Healthcare, Aarti Drugs, Themis Medicare.
Market Cap of SMS Pharmaceuticals is ₹2,709 Crs.
While the median market cap of its peers are ₹2,533 Crs.
SMS Pharmaceuticals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||||||||
| Investor Presentation | May Aug Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar Jun Aug Sep Dec | Sep Dec | |||||||||||||
| Conference Call | Mar Nov | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
